Skip to main content
DH
NASDAQ Technology

Definitive Healthcare Q3 Revenue $54.7M, Down 9%; Profit Beats, No Guidance on Advent Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.13
Mkt Cap
$163.668M
52W Low
$0.61
52W High
$3
52W Position info
85% above low
Off High info
62% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

DH sits 85% above its 52-week low of $0.61.

Summary

Definitive Healthcare posted Q3 revenue of $54.7M (down 9%) with Adjusted EBITDA of $15.7M, but gave no guidance and held no call while Advent's $1.02/share take-private proposal is pending.

Updates

  1. · Reuters — Q3 revenue fell 9% yr/yr to $54.65 mln, slightly beating the $54.59 mln consensus estimate from 5 analysts.

    • Q3 Profitability — Q3 gross profit was $42.23 mln, with a pretax loss of $5.91 mln and a net loss of $5.41 mln.
    • Adjusted Net Income — Adjusted net income declined compared to the prior year.
    All 4 details
    • Q3 gross profit was $42.23 mln
    • Q3 pretax loss was $5.91 mln
    • Adjusted net income declined compared to the prior year
    • Q3 net loss $5.41 mln

Key Events · Earnings and Guidance · DH

  • Q3 Revenue Falls 9% to $54.7M

    Revenue came in at $54.7 million, down 9% from $60.0 million in Q3 2025, within the guidance range.

  • Profitability Holds on Adjusted Basis

    Adjusted EBITDA was $15.7 million (29% of revenue) and Adjusted Net Income was $8.8 million, or $0.06 per diluted share; the net loss narrowed to $(5.4) million from $(17.8) million a year ago.

  • Cash Generation Remains Solid

    Cash flow from operations was $11.4 million and Unlevered Free Cash Flow was $13.0 million in the quarter, leaving cash and equivalents of $177.1 million at September 30, 2026.

  • No Guidance or Call on Advent Deal

    Citing the September 2, 2026 non-binding indication of interest from Advent International, the company will not provide financial guidance or host a conference call for Q3 2026.


Analysis · DH · Technology

Revenue fell 9% to $54.7M, yet the company stayed solidly profitable on an adjusted basis, with Adjusted EBITDA of $15.7M (29% of revenue) and $13.0M of unlevered free cash flow. What matters more is what's missing: management withheld guidance and skipped the earnings call because Advent International's $1.02-per-share take-private proposal is still pending. The quarter thus serves as a status check on the business rather than a forward-looking update, and the stock now trades on deal probability, not on these numbers.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DH was trading at $1.13 on NASDAQ in the Technology sector, with a market capitalization of approximately $163.7M. The 52-week trading range was $0.61 to $3.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DH - Latest Insights

DH
Oct 01, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.9361
Real-time Price: $1.23 info
Change: +$0.2889 (+31%) info
Market Cap: $178.667M info
DH
Sep 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.23 info
Change: +$0.195 (+19%) info
Market Cap: $178.667M info
DH
Sep 02, 2026, 9:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.23 info
Change: +$0.175 (+17%) info
Market Cap: $178.667M info
DH
Sep 02, 2026, 8:40 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $1.23 info
Change: +$0.215 (+21%) info
Market Cap: $178.667M info
DH
Sep 02, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $1.23 info
Change: +$0.275 (+29%) info
Market Cap: $178.667M info